The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. Keeping that in mind, here is one stock under $50 with huge potential and two that could be down big.
Two Stocks Under $50 to Sell:
Baldwin Insurance Group (BWIN)
Share Price: $25.42
Rebranded from BRP Group in May 2024, Baldwin Insurance Group (NASDAQ: BWIN) is an independent insurance distribution company that provides tailored insurance, risk management, and employee benefits solutions to businesses and individuals.
Why Does BWIN Fall Short?
- Static adjusted operating margin over the last five years shows it couldn’t become more efficient
- Investments to defend its competitive moat have ramped up over the last five years as its free cash flow margin decreased by 5.1 percentage points
- High net-debt-to-EBITDA ratio of 6× could force the company to raise capital on unfavorable terms if market conditions deteriorate
At $25.42 per share, Baldwin Insurance Group trades at 12.1x forward P/E. To fully understand why you should be careful with BWIN, check out our full research report (it’s free).
LifeStance Health Group (LFST)
Share Price: $10.97
With over 6,600 licensed mental health professionals treating more than 880,000 patients annually, LifeStance Health (NASDAQ: LFST) provides outpatient mental health services through a network of clinicians offering psychiatric evaluations, psychological testing, and therapy across 33 states.
Why Does LFST Give Us Pause?
- Modest revenue base of $1.49 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
- Low free cash flow margin of 0.9% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
- Negative returns on capital show management lost money while trying to expand the business
LifeStance Health Group is trading at $10.97 per share, or 32.7x forward P/E. If you’re considering LFST for your portfolio, see our FREE research report to learn more.
One Stock Under $50 to Watch:
Helmerich & Payne (HP)
Share Price: $33
Operating the largest fleet of super-spec rigs in North America with technology that can drill horizontal wells over two miles long, Helmerich & Payne (NYSE: HP) provides drilling rigs and crews to oil and gas companies that need wells drilled to extract hydrocarbons from underground.
Why Should HP Be on Your Watchlist?
- Market share has increased this cycle as its 32.2% annual revenue growth over the last five years was exceptional
- Economies of scale give it more fixed cost leverage than its smaller competitors
- EBITDA profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient
Helmerich & Payne’s stock price of $33 implies a valuation ratio of 32.6x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
